| Dr Omar Abdul Fattah Abdul Ghani, MBBS | |
|
91-2135 Fort Weaver Rd Fl 3, Ewa Beach, HI 96706-1940 | |
| (808) 691-3340 | |
| (808) 691-3151 |
| Full Name | Dr Omar Abdul Fattah Abdul Ghani |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 17 Years |
| Location | 91-2135 Fort Weaver Rd Fl 3, Ewa Beach, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982916839 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-17005 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Kona Community Hospital | Kealakekua, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Queen's North Hawaii Community Hospital | 0143116293 | 58 |
| Queens University Medical Group | 2466831557 | 543 |
| The Queens Medical Center | 3476454067 | 187 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.
A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
› Verified 8 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.
A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
› Verified 8 days ago
| Entity Name | Queen's North Hawaii Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528049814 PECOS PAC ID: 0143116293 Enrollment ID: O20040225000562 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.
A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
› Verified 8 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.
A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Omar Abdul Fattah Abdul Ghani, MBBS 91-2135 Fort Weaver Rd Fl 3, Ewa Beach, HI 96706-1940 Ph: (808) 691-3340 | Dr Omar Abdul Fattah Abdul Ghani, MBBS 91-2135 Fort Weaver Rd Fl 3, Ewa Beach, HI 96706-1940 Ph: (808) 691-3340 |
News Archive
College students who participate in fun, peer-directed activities that openly and honestly address mental illness are significantly less likely to stigmatize people with these conditions, according to a new study led by researchers at Indiana University.
Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.
A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).
Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
› Verified 8 days ago
Mr. Kevin Marc Salire, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 91-2135 Fort Weaver Rd Fl 3, Ewa Beach, HI 96706 Phone: 808-691-3340 Fax: 808-691-3345 | |
Dr. Brian Hunter Levins Jr., M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 91-2301 Old Ft Weaver Rd, Ewa Beach, HI 96706 Phone: 808-677-2587 | |
Mrs. Aurora C Mariani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 91-2139 Fort Weaver Rd. #307, Ewa Beach, HI 96706 Phone: 808-680-0008 Fax: 808-680-0049 | |
Laverne Arabella Kia, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 912139 Fort Weaver Road, Suite 209, Ewa Beach, HI 96706 Phone: 808-671-4530 Fax: 808-676-1066 | |
Dr. Kimberly Kyle, D.O Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-691-3000 | |
Albert Lin, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 91-2141 Fort Weaver Rd, Ewa Beach, HI 96706 Phone: 808-678-7000 | |
Daniel K Chan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 91-2135 Fort Weaver Rd Fl 3, Ewa Beach, HI 96706 Phone: 808-691-3150 Fax: 808-691-3153 |